Skip to main content
Chaptra
Cover of Alexithymia: State of the Art and Controversies. Clinical and Neuroscientific Evidence

Alexithymia: State of the Art and Controversies. Clinical and Neuroscientific Evidence

Written by Katharina S. Goerlich,Masako Hosoi,Lorys Castelli,Valentina Tesio

Not rated yet — tap a star to review it

158 pages, about 3 hours of reading

Chaptra reads alongside you — AI insights, chapter breakdowns and reader discussions for every book. Join free

About this book

This work by Katharina S. Goerlich, Masako Hosoi, Lorys Castelli, Valentina Tesio offers readers a unique literary experience.

Read it with a club

Small groups reading the same books and talking as they go.

All clubs
A stack of paperbacks tied with a ribbon

News

  • 1 member
  • 1,813 discussions
  • Active 15h ago

Read Alexithymia: State of the Art and Controversies. Clinical and Neuroscientific Evidence alongside people who are reading it too.

Chaptra Prime — paid clubs, every club feature, and unlimited reading support, for $5 a month or $60 once.

See Prime

Reading guide

Themes, characters and key ideas in Alexithymia: State of the Art and Controversies. Clinical and Neuroscientific Evidence, written by Chaptra AI.

  • about 8 hours
  • advanced
  • informative
  • analytical
  • rigorous

This academic volume, "Alexithymia: State of the Art and Controversies. Clinical and Neuroscientific Evidence," offers a comprehensive, interdisciplinary examination of alexithymia, a personality construct characterized by difficulties in identifying and describing one's own emotions. Edited by leading researchers, the book consolidates current clinical understanding with emerging neuroscientific insights, highlighting both established knowledge and ongoing debates. It serves as a critical resource for clinicians, researchers, and students seeking to understand the complex facets of alexithymia from both psychological and biological perspectives, addressing its definition, measurement, underlying mechanisms, and clinical implications. The text rigorously explores the multifaceted nature of this condition, emphasizing its relevance across various mental and physical health contexts.

Alexithymia represents a fundamental deficit in emotional processing, extending beyond mere emotional suppression to an inability to cognitively elaborate and verbally express affective states.

Key themes

Definition and Measurement of Alexithymia
This theme explores the core conceptualization of alexithymia, tracing its historical development from Sifneos's initial observations to contemporary multi-component models. It delves into the various instruments used for its assessment, such as the Toronto Alexithymia Scale (TAS-20) and the Bermond-Vorst Alexithymia Questionnaire (BVAQ), critically evaluating their psychometric properties, strengths, and limitations. The book likely discusses the ongoing debate about whether alexithymia is a unitary construct or comprises distinct facets (e.g., difficulty identifying feelings vs. difficulty describing feelings).
Neurobiological Underpinnings of Alexithymia
This theme focuses on the biological basis of alexithymia, integrating findings from neuroimaging (fMRI, EEG), neurochemistry, and genetic studies. It explores the neural circuits and brain regions hypothesized to be involved in emotional processing, such as the anterior cingulate cortex, insula, amygdala, and prefrontal cortex, and how their altered function or connectivity might contribute to alexithymic traits. The book likely discusses the role of interoception (the sense of the physiological condition of the body) and its neural correlates in the experience and identification of emotions.
Clinical Correlates and Comorbidity
This theme examines the widespread clinical relevance of alexithymia, exploring its high prevalence across various psychiatric disorders (e.g., depression, anxiety disorders, eating disorders, PTSD, autism spectrum disorder) and medical conditions (e.g., chronic pain, functional somatic syndromes, cardiovascular disease). It discusses how alexithymia can impact symptom presentation, hinder therapeutic progress, and affect overall prognosis, highlighting its role as a transdiagnostic factor. The book likely addresses the 'chicken or egg' question regarding whether alexithymia is a predisposing factor or a consequence of these conditions.

Worth discussing

What are the primary challenges in developing a universally accepted definition and diagnostic criteria for alexithymia, and how does this book address them?

Chapter-by-chapter breakdowns, character arcs and the full thematic analysis come with a free account.

Discussions

No one has started one yet

Join

Questions this book opens up

No discussions yet

Be the first to start a discussion about this book!

Sign up to start the discussion

Reviews

No reviews yet

Be the first to review this book!